[en] We examined the biological activity and immunological reactivity of four mutants of human PRL. Two were mutants that changed the ability of human PRL to inhibit rat PRL storage when transfected into a rat pituitary cell line:mutations S34A and N31T. Two mutations were in regions of PRL that are highly conserved. One, des(3-11)-PRL, removed the N-terminal cystine loop that most PRLs, except those from certain fish, have, and no GHs have. The other, S90A, mutated a serine that is present in all PRLs but those from some fish and in all GHs. The immunological properties of des(3-11)-PRL were reduced 10-fold compared to those of wildtype human PRL in a RIA using NIH antihuman PRL-3, AFP C11580; the others were similar to those of wild-type PRL. The biological activity of des(3-11)-PRL was the most affected; activity was reduced about 8-fold compared to that of wild-type PRL in the Nb2 cell assay. The activities of the others were similar to that of the wild type. Serine 90 may be partially buried by loops connecting the alpha-helixes. The mutation of serine 90 did not affect the stability of the molecule in vitro, determined by comparing the red shift in tryptophan fluorescence that occurs with increasing concentrations of urea in S90A and wild-type PRL. The activity of S34A and N31T mutations indicates there is no correlation between biological activity and ability to affect storage. The N-terminal cystine loop may be conserved because it is needed for biological activity, but the conservation of serine 90 in GH and PRL must be determined by other properties, such as spacial requirements.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Rhee, Harrison K; Yale University School of Medicine
Sun, Zhenyu; Yale University School of Medicine
Kim, Steve S; Yale University School of Medicine
Goffin, Vincent
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Dannies, Priscilla S; Yale University School of Medicine
Language :
English
Title :
Biological activity and immunological reactivity of human prolactin mutants
Publication date :
1995
Journal title :
Endocrinology
ISSN :
0013-7227
eISSN :
1945-7170
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Nicoll CS, Mayer GL, Russell SM 1986 Structural features of pro-lactins and growth hormones that can be related to their biological properties [published erratum appears in Endocr Rev 8:43, 1987], Endocr Rev 7:169-203 (Review)
de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
Cunningham BC, Wells JA1991 Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88: 3407-3411
Cunningham BC, Henner DJ, Wells JA 1990 Engineering human prolactin to bind to the human growth hormone receptor. Science 24:1461-1465
Somers W, Ultsch M, De Vos AM, Kossiakoff A A 1994 The x-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478-481
Cunningham BC, Bass S, Fuh G, Wells JA 1990 Zinc mediation of the binding of human growth hormone to the human prolactin receptor Science 250:1709-1712
Fuh G, Colosi P, Wood WI, Wells JA 1993 Mechanism-based design of prolactin receptor antagonists. J Biol Chem 268:5376-5381
Cunningham BC, Ultsch M, De Vos AM, Mulkemn MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
Goffin V, Struman I, Mainfroid V, Kinet S, Martial JA 1994 Evidence for a second receptor binding site on human prolactin. J Biol Chem 269:32598-32606
Goffin V, Struman I, Goormaghtigh E, Martial JA 1993 The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties. Eur J Biochem 214:483-490
Goffin V, Norman M, Martial JA 1992 Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Mol Endocrinol 6:1381-1392
Luck DN, Huyer M, Gout PW, Beer CT, Smith M1991 Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures. Mol Endocrinol 5:1880-1886
Luck DN, Gout PW, Kelsay K, Atkinson T, Beer CT, Smith M1990 Recombinant methionyl bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regions. Mol Endocrinol 4:1011-1016
Deleted in proof
Arrandale JM, Dannies PS 1994 Inhibition of rat prolactin (PRL) storage by coexpression of human PRL. Mol Endocrinol 8:1083-1090
Paris N, Rentier-Delrue F, Defontaine A, Goffin V, Lebrun JJ, Mercier L, Martial JA 1990 Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem 12: 436-449
Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG1980 A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063
Holzman TF, Dougherty Jr JJ, Brems DN, MacKenzie NE 1990 pH-induced conformational states of bovine growth hormone. Biochemistry 29:1255-1261
Aloj SM, Edelhoch H1970 Conformational similarity of ovine prolactin and bovine growth hormone. Proc Natl Acad Sci USA 66: 830-836
Kawauchi H, Bewley TA, Li CH 1976 Alkalin titrations of human somatotropin, human choriomammotropin and ovine prolactin by circular dichroism and fluorescence. Biochim Biophys Acta 446:525-535
Doneen BA, Bewley TA, Li CH 1979 Studies on prolactin. Selective reduction of the disulfide bonds of the ovine hormone. Biochemistry 18:4851-4860
Gertler A, Hauser SD, Sakai E, Vashdi D, Staten N, Freeman JJ, Krivi GG 1992 Preparation, purification, and determination of the biological activities of 12 N terminus-truncated recombinant analogues of bovine placental lactogen. J Biol Chem 267:12655-12659
Maruyama O, Kato T, Wakabayashi K, Kato Y 1994 Amino acids in the amino terminal region of the rat prolactin contribute to PRL-receptor binding and NB2 cell proliferation activity. Biochem Biophys Res Commun 205:312-319
Kim BG, Brooks CL 1993 Isolation and characterization of phos-phorylated bovine prolactin. Biochem J 296:41-47
Oetting WS, Tuazon PT, Traugh JA, Walker AM 1986 Phosphorylation of prolactin. J Biol Chem 261:1649-1652
Mastro RM, Dannies PS 1995 Lack of correlation of distribution of prolactin charge isoforms with induction of prolactin storage. Endocrinology 136:69-74
Wicks JR, Brooks CL, The effects of phosphorylation on the biological activity of bovine prolactin. 76th Annual Meeting of the Endocrine Society, Anaheim CA, 1994 (Abstract 922)
